|
G |
Arsb |
arylsulfatase B |
decreases abundance |
ISO |
ARSB protein results in decreased abundance of Chondroitin Sulfates |
CTD |
PMID:29794138 |
|
NCBI chr 2:25,002,210...25,162,675
Ensembl chr 2:25,002,346...25,162,671
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
multiple interactions |
EXP |
[icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Chondroitin Sulfates |
CTD |
PMID:21436127 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to BDNF protein |
CTD |
PMID:15385557 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
C3 |
complement C3 |
increases cleavage |
ISO |
Chondroitin Sulfates analog results in increased cleavage of C3 protein |
CTD |
PMID:18434646 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C5 |
complement C5 |
increases cleavage |
ISO |
Chondroitin Sulfates analog results in increased cleavage of C5 protein |
CTD |
PMID:18434646 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP3 protein]; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP3 mRNA] |
CTD |
PMID:17879260 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein]; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP7 mRNA] |
CTD |
PMID:17879260 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Chondroitin Sulfates inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] |
CTD |
PMID:12736501 PMID:15089041 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
affects binding |
ISO |
Chondroitin Sulfates binds to CCL2 protein |
CTD |
PMID:16385517 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL11 protein]; Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL9 protein]; Chondroitin Sulfates promotes the reaction [CTSB protein results in increased cleavage of benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide] |
CTD |
PMID:25833952 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSK protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide]; Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL2 protein]; Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL3 protein] |
CTD |
PMID:25833952 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Ctsl |
cathepsin L |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSL protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSL protein results in increased degradation of CXCL11 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL2 protein] |
CTD |
PMID:25833952 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Ctss |
cathepsin S |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSS protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL2 protein] |
CTD |
PMID:25833952 |
|
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL1 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSK protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSL protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSS protein results in increased degradation of CXCL10 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL11 protein]; Chondroitin Sulfates inhibits the reaction [CTSL protein results in increased degradation of CXCL11 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL2 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL2 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL2 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL1 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL9 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
F12 |
coagulation factor XII |
increases activity |
ISO |
Chondroitin Sulfates analog results in increased activity of F12 protein |
CTD |
PMID:18434646 |
|
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein; Chondroitin Sulfates analog binds to FGF10 protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf16 |
fibroblast growth factor 16 |
affects binding |
EXP |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF16 protein; Chondroitin Sulfates analog binds to FGF16 protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr X:70,816,658...70,828,028
Ensembl chr X:70,817,433...70,878,717
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF18 protein; Chondroitin Sulfates analog binds to FGF18 protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein; Chondroitin Sulfates analog binds to FGF2 protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
increases activity |
ISO |
Chondroitin Sulfates analog results in increased activity of FGF23 protein |
CTD |
PMID:16081635 |
|
NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:159,914,272...159,923,821
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to GDNF protein |
CTD |
PMID:15385557 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to HBEGF protein; Chondroitin Sulfates analog binds to HBEGF protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein; [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGES protein; [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein; [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in increased expression of TIMP3 mRNA; [Glucosamine co-treated with Chondroitin Sulfates] inhibits the reaction [IL1B protein results in increased secretion of Dinoprostone]; [Glucosamine co-treated with Chondroitin Sulfates] inhibits the reaction [IL1B protein results in increased secretion of Nitrites] |
CTD |
PMID:17605605 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
multiple interactions |
ISO |
TNFAIP6 protein promotes the reaction [ITIH1 protein binds to Chondroitin Sulfates] |
CTD |
PMID:25561734 |
|
NCBI chr16:6,122,246...6,136,363
Ensembl chr16:6,122,248...6,136,363
|
|
G |
Klkb1 |
kallikrein B1 |
increases activity |
ISO |
Chondroitin Sulfates analog results in increased activity of KLKB1 protein |
CTD |
PMID:18434646 |
|
NCBI chr16:46,958,634...46,982,054
Ensembl chr16:46,958,707...46,982,053
|
|
G |
Mdk |
midkine |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein; Chondroitin Sulfates analog binds to MDK protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates] results in decreased expression of MMP3 mRNA; [Glucosamine co-treated with Chondroitin Sulfates] results in decreased secretion of MMP3 protein |
CTD |
PMID:20110869 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
[Chondroitin Sulfates co-treated with Hyaluronic Acid] inhibits the reaction [Carbon Tetrachloride results in increased activity of MPO protein] |
CTD |
PMID:14697411 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of NFKB1 protein] |
CTD |
PMID:17879260 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in decreased expression of NFKBIA protein] |
CTD |
PMID:17879260 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein |
CTD |
PMID:17605605 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]; Genistein inhibits the reaction [Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]] |
CTD |
PMID:16945567 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]; Genistein inhibits the reaction [Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]] |
CTD |
PMID:16945567 |
|
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Ptges |
prostaglandin E synthase |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGES protein |
CTD |
PMID:17605605 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein |
CTD |
PMID:17605605 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptn |
pleiotrophin |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein; Chondroitin Sulfates analog binds to PTN protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
affects binding |
ISO |
PTPN11 protein binds to Chondroitin Sulfates |
CTD |
PMID:29794138 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of RELA protein] |
CTD |
PMID:17879260 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in increased expression of TIMP3 mRNA |
CTD |
PMID:17605605 |
|
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP ISO |
[Chondroitin Sulfates co-treated with Hyaluronic Acid] inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein] [Glucosamine co-treated with Chondroitin Sulfates] results in decreased expression of TNF |
CTD |
PMID:14697411 PMID:20110869 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
multiple interactions |
ISO |
TNFAIP6 protein promotes the reaction [ITIH1 protein binds to Chondroitin Sulfates] |
CTD |
PMID:25561734 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
multiple interactions increases expression |
ISO |
[Chondroitin Sulfates co-treated with Cholecalciferol] results in increased expression of TNFRSF11B mRNA; [Chondroitin Sulfates co-treated with Cholecalciferol] results in increased expression of TNFRSF11B protein; [Chondroitin Sulfates co-treated with Glucosamine co-treated with Cholecalciferol] results in increased expression of TNFRSF11B mRNA; [Chondroitin Sulfates co-treated with Glucosamine co-treated with Cholecalciferol] results in increased expression of TNFRSF11B protein; [Chondroitin Sulfates co-treated with Glucosamine] results in increased expression of TNFRSF11B mRNA; [Chondroitin Sulfates co-treated with Glucosamine] results in increased expression of TNFRSF11B protein Chondroitin Sulfates results in increased expression of TNFRSF11B protein |
CTD |
PMID:17996099 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions decreases expression |
ISO |
[Chondroitin Sulfates co-treated with Glucosamine] inhibits the reaction [Cholecalciferol results in increased expression of TNFSF11 mRNA]; Chondroitin Sulfates inhibits the reaction [Cholecalciferol results in increased expression of TNFSF11 mRNA]; Chondroitin Sulfates inhibits the reaction [Glucosamine results in increased expression of TNFSF11 mRNA] Chondroitin Sulfates results in decreased expression of TNFSF11 mRNA |
CTD |
PMID:17996099 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Vegfa |
vascular endothelial growth factor A |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to VEGFA protein |
CTD |
PMID:15385557 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to BDNF protein |
CTD |
PMID:15385557 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
F2 |
coagulation factor II, thrombin |
multiple interactions |
ISO |
[Dermatan Sulfate co-treated with SERPIND1 protein] results in decreased activity of F2 protein |
CTD |
PMID:11805133 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein |
CTD |
PMID:15385557 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf16 |
fibroblast growth factor 16 |
affects binding |
EXP |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF16 protein |
CTD |
PMID:15385557 |
|
NCBI chr X:70,816,658...70,828,028
Ensembl chr X:70,817,433...70,878,717
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF18 protein |
CTD |
PMID:15385557 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
affects binding increases activity |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein Dermatan Sulfate analog results in increased activity of FGF2 protein |
CTD |
PMID:15385557 PMID:15563459 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
increases activity |
ISO |
Dermatan Sulfate analog results in increased activity of FGF23 protein |
CTD |
PMID:16081635 |
|
NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:159,914,272...159,923,821
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
increases activity |
ISO |
Dermatan Sulfate analog results in increased activity of FGF7 protein |
CTD |
PMID:15563459 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to GDNF protein |
CTD |
PMID:15385557 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to HBEGF protein |
CTD |
PMID:15385557 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Mdk |
midkine |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein |
CTD |
PMID:15385557 |
|
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
decreases expression |
ISO |
Dermatan Sulfate results in decreased expression of PDGFRA mRNA |
CTD |
PMID:16945567 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
decreases expression |
ISO |
Dermatan Sulfate results in decreased expression of PDGFRB mRNA |
CTD |
PMID:16945567 |
|
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Ptn |
pleiotrophin |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein |
CTD |
PMID:15385557 |
|
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
|
|
G |
Serpind1 |
serpin family D member 1 |
multiple interactions |
ISO |
[Dermatan Sulfate co-treated with SERPIND1 protein] results in decreased activity of F2 protein |
CTD |
PMID:11805133 |
|
NCBI chr11:83,664,517...83,675,593
Ensembl chr11:83,664,518...83,675,519
|
|
G |
Vegfa |
vascular endothelial growth factor A |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to VEGFA protein |
CTD |
PMID:15385557 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Heparitin Sulfate inhibits the reaction [Hydrogen Peroxide results in increased degradation of [CCL5 protein binds to CCL5 protein]]; Heparitin Sulfate inhibits the reaction [Hydrogen Peroxide results in increased degradation of CCL5 protein] |
CTD |
PMID:21963154 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
CXCL10 protein inhibits the reaction [CXCL1 protein binds to Heparitin Sulfate] |
CTD |
PMID:12549928 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
CXCL10 protein inhibits the reaction [CXCL1 protein binds to Heparitin Sulfate] |
CTD |
PMID:12549928 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
CXCL10 protein inhibits the reaction [CXCL1 protein binds to Heparitin Sulfate] |
CTD |
PMID:12549928 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
affects binding |
ISO |
FGF1 protein binds to Heparitin Sulfate binds to FGFR1 protein |
CTD |
PMID:12604602 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects activity |
ISO |
Heparitin Sulfate affects the activity of FGF10 protein |
CTD |
PMID:12781692 PMID:12818887 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions affects binding increases activity |
ISO |
Heparitin Sulfate binds to and affects the activity of FGF2 protein Heparitin Sulfate binds to FGF2 protein Heparitin Sulfate analog results in increased activity of FGF2 protein |
CTD |
PMID:12460940 PMID:15464572 PMID:15958608 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf4 |
fibroblast growth factor 4 |
affects binding |
ISO |
Heparitin Sulfate binds to FGF4 protein |
CTD |
PMID:15769253 |
|
NCBI chr 1:200,023,937...200,027,793
Ensembl chr 1:200,024,056...200,025,466
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
affects binding |
ISO |
Heparitin Sulfate binds to FGF7 protein |
CTD |
PMID:15769253 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
affects binding increases activity |
ISO |
Heparitin Sulfate binds to FGF8 protein alternative form Heparitin Sulfate analog results in increased activity of FGF8 protein |
CTD |
PMID:12460940 PMID:15769253 |
|
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
affects binding increases activity |
ISO |
FGF1 protein binds to Heparitin Sulfate binds to FGFR1 protein Heparitin Sulfate analog results in increased activity of FGFR1 protein alternative form |
CTD |
PMID:12460940 PMID:12604602 |
|
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
decreases activity |
ISO |
Heparitin Sulfate analog results in decreased activity of FGFR2 protein mutant form |
CTD |
PMID:16373332 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
increases activity |
ISO |
Heparitin Sulfate analog results in increased activity of FGFR3 protein alternative form |
CTD |
PMID:12460940 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
affects binding |
ISO |
Heparitin Sulfate analog binds to FGFR4 protein |
CTD |
PMID:11278860 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
affects degradation |
ISO |
GNS affects the degradation of Heparitin Sulfate |
CTD |
PMID:3391615 |
|
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
|
|
G |
Gpc1 |
glypican 1 |
affects binding multiple interactions |
ISO |
GPC1 protein binds to Heparitin Sulfate GPC1 protein modified form results in increased cleavage of [GPC1 protein binds to Heparitin Sulfate]; nitroxyl affects the reaction [GPC1 protein results in increased cleavage of [GPC1 protein binds to Heparitin Sulfate]]; Zinc affects the reaction [GPC1 protein results in increased cleavage of [GPC1 protein binds to Heparitin Sulfate]] |
CTD |
PMID:12732622 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
Hpse |
heparanase |
multiple interactions decreases abundance affects abundance |
ISO EXP |
[Heparin results in decreased activity of HPSE protein] which affects the abundance of Heparitin Sulfate; [phosphomannopentaose sulfate results in decreased activity of HPSE protein] which affects the abundance of Heparitin Sulfate HPSE protein results in decreased abundance of Heparitin Sulfate HPSE protein affects the abundance of Heparitin Sulfate |
CTD |
PMID:16899518 PMID:17121850 |
|
NCBI chr14:8,896,593...8,937,011
Ensembl chr14:8,896,593...8,937,010
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK1 protein] |
CTD |
PMID:19937756 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:19937756 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Ndst1 |
N-deacetylase and N-sulfotransferase 1 |
multiple interactions |
ISO |
Heparitin Sulfate affects the susceptibility to [NDST1 protein co-treated with NDST2 protein]; Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK1 protein]; Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:19937756 |
|
NCBI chr18:54,136,887...54,199,545
Ensembl chr18:54,140,779...54,178,191
|
|
G |
Ndst2 |
N-deacetylase and N-sulfotransferase 2 |
multiple interactions |
ISO |
Heparitin Sulfate affects the susceptibility to [NDST1 protein co-treated with NDST2 protein]; Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK1 protein]; Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:19937756 |
|
NCBI chr15:3,563,515...3,573,801
Ensembl chr15:3,563,358...3,573,801
|
|
G |
Prnp |
prion protein |
affects binding |
ISO |
PRNP protein modified form binds to Heparitin Sulfate metabolite |
CTD |
PMID:18717736 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
multiple interactions |
ISO |
[N6L peptide binds to Heparitin Sulfate] which results in increased secretion of TIMP3 protein |
CTD |
PMID:23109338 |
|
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Heparitin Sulfate promotes the reaction [Dipyridamole results in increased secretion of VEGFA protein] |
CTD |
PMID:20067761 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
affects activity multiple interactions |
ISO |
Heparin affects the activity of ABCC1 protein Heparin affects the reaction [ABCC1 protein affects the transport of Doxorubicin] |
CTD |
PMID:17352253 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ACKR3 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
Heparin analog inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:16904936 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actr3 |
actin related protein 3 |
increases expression |
EXP |
Heparin results in increased expression of ACTR3 protein |
CTD |
PMID:17488504 |
|
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ADAMTS1 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
Heparin inhibits the reaction [AGT protein affects the localization of Calcium] |
CTD |
PMID:21613610 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of AKT1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:14966081 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
EXP |
Heparin results in increased expression of ANXA6 protein |
CTD |
PMID:17488504 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Apcs |
amyloid P component, serum |
increases expression |
ISO |
Heparin results in increased expression of APCS protein |
CTD |
PMID:17162433 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
Copper promotes the reaction [Heparin binds to APP protein]; Zinc promotes the reaction [Heparin binds to APP protein] |
CTD |
PMID:25835329 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
increases expression |
EXP |
Heparin results in increased expression of ARHGDIA protein |
CTD |
PMID:17488504 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ATP1B1 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
Heparin results in increased expression of BAX protein Heparin inhibits the reaction [arsenite results in increased expression of BAX protein] |
CTD |
PMID:11787776 PMID:26677073 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
ISO |
Heparin results in increased expression of BCL2 protein Heparin inhibits the reaction [arsenite results in decreased expression of BCL2 protein] |
CTD |
PMID:11787776 PMID:15205081 PMID:15671997 PMID:26677073 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
multiple interactions decreases expression |
ISO |
Heparin inhibits the reaction [BMP6 protein results in increased expression of HAMP mRNA]; Heparin inhibits the reaction [BMP6 protein results in increased secretion of HAMP protein modified form] Heparin results in decreased expression of BMP6 mRNA |
CTD |
PMID:25633564 |
|
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bmpr1a |
bone morphogenetic protein receptor type 1A |
decreases expression |
ISO |
Heparin results in decreased expression of BMPR1A mRNA |
CTD |
PMID:25633564 |
|
NCBI chr16:9,736,390...9,829,825
Ensembl chr16:9,736,630...9,780,616
|
|
G |
C3 |
complement C3 |
decreases expression |
ISO |
Heparin results in decreased expression of C3 protein |
CTD |
PMID:7948777 PMID:10568115 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C5 |
complement C5 |
decreases expression |
ISO |
Heparin results in decreased expression of C5 protein |
CTD |
PMID:7948777 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Cacna1e |
calcium voltage-gated channel subunit alpha1 E |
multiple interactions |
EXP |
Heparin affects the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]] |
CTD |
PMID:12663092 |
|
NCBI chr13:66,574,659...67,063,443
Ensembl chr13:66,581,920...66,894,450
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
EXP |
Heparin results in increased expression of CAPG protein |
CTD |
PMID:17488504 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Capn1 |
calpain 1 |
multiple interactions |
ISO |
Heparin inhibits the reaction [Paraoxon results in increased expression of CAPN1 protein] |
CTD |
PMID:26998625 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Capn2 |
calpain 2 |
multiple interactions |
ISO |
Heparin inhibits the reaction [Paraoxon results in increased expression of CAPN2 protein] |
CTD |
PMID:26998625 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO |
Heparin inhibits the reaction [Paraoxon results in increased expression of and affects the activity of CASP12 protein]; Heparin inhibits the reaction [Paraoxon results in increased expression of CASP12 protein] |
CTD |
PMID:20079824 PMID:26998625 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
decreases activity multiple interactions |
ISO EXP |
Heparin results in decreased activity of CASP3 protein Heparin inhibits the reaction [Paraoxon results in increased expression of and affects the activity of CASP3 protein] Heparin promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; Lithium Chloride inhibits the reaction [Heparin promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]] |
CTD |
PMID:16556679 PMID:26998625 PMID:30377735 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
increases activity |
ISO |
Heparin results in increased activity of CAT protein |
CTD |
PMID:12218949 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
affects binding multiple interactions |
ISO |
Heparin binds to CCL11 protein Heparin inhibits the reaction [PLG protein affects the degradation of CCL11 protein] |
CTD |
PMID:17384413 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
EXP |
Heparin results in decreased expression of CCL2 protein |
CTD |
PMID:11053056 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cd40lg |
CD40 ligand |
decreases expression |
ISO |
Heparin results in decreased expression of CD40LG protein |
CTD |
PMID:16391376 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
Heparin results in increased expression of CDKN1A protein |
CTD |
PMID:10926548 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression increases expression |
ISO |
Heparin analog results in decreased expression of CDKN1B protein Heparin analog results in increased expression of CDKN1B protein |
CTD |
PMID:18057711 PMID:20201787 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
affects binding |
ISO |
Heparin binds to COL18A1 protein alternative form |
CTD |
PMID:15604266 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Crp |
C-reactive protein |
increases expression |
ISO |
Heparin results in increased expression of CRP protein |
CTD |
PMID:16391376 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf3 |
colony stimulating factor 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of CSF3 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
Heparin promotes the reaction [Doxorubicin results in decreased expression of CTNNB1 protein]; Lithium Chloride inhibits the reaction [Heparin promotes the reaction [Doxorubicin results in decreased expression of CTNNB1 protein]] |
CTD |
PMID:30377735 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
EXP |
Heparin inhibits the reaction [endotoxin, Escherichia coli results in increased expression of CXCL10 mRNA] |
CTD |
PMID:31813902 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
Heparin analog results in decreased expression of CXCL12 mRNA; Heparin analog results in decreased expression of CXCL12 protein |
CTD |
PMID:20201787 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of CXCL2 mRNA]; Heparin inhibits the reaction [Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of CXCL2 protein]] |
CTD |
PMID:16401727 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
decreases expression |
ISO |
Heparin analog results in decreased expression of CXCR4 mRNA; Heparin analog results in decreased expression of CXCR4 protein |
CTD |
PMID:20201787 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Ddah2 |
DDAH family member 2, ADMA-independent |
decreases expression |
EXP |
Heparin results in decreased expression of DDAH2 protein |
CTD |
PMID:17488504 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Des |
desmin |
decreases expression |
EXP |
Heparin results in decreased expression of DES protein |
CTD |
PMID:9111513 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
Heparin analog results in decreased expression of E2F1 protein |
CTD |
PMID:20201787 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions decreases expression decreases secretion |
ISO EXP |
Heparin inhibits the reaction [F2 protein results in increased expression of EDN1 mRNA]; Heparin inhibits the reaction [F2 protein results in increased secretion of EDN1 protein] Heparin results in decreased expression of EDN1 mRNA Heparin inhibits the reaction [EDN1 protein results in increased abundance of Calcium]; Heparin inhibits the reaction [EDN1 protein results in increased abundance of Inositol 1,4,5-Trisphosphate] Heparin results in decreased secretion of EDN1 protein |
CTD |
PMID:1443220 PMID:7509996 PMID:8408661 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egf |
epidermal growth factor |
decreases activity |
ISO |
Heparin results in decreased activity of EGF protein |
CTD |
PMID:12714831 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression increases phosphorylation |
ISO |
Heparin results in decreased expression of EGFR mRNA; Heparin results in decreased expression of EGFR protein Heparin results in increased phosphorylation of EGFR protein |
CTD |
PMID:16475731 PMID:16556679 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGLN3 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
F10 |
coagulation factor X |
decreases activity |
ISO EXP |
Heparin results in decreased activity of F10 protein |
CTD |
PMID:8950779 |
|
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F2 |
coagulation factor II, thrombin |
multiple interactions decreases expression increases expression |
ISO |
F2 protein promotes the reaction [Heparin results in increased abundance of Nitric Oxide]; Heparin deficiency results in increased cleavage of and results in increased activity of F2 protein; Heparin deficiency results in increased expression of [SERPINC1 protein binds to F2 protein]; Heparin inhibits the reaction [F2 protein affects the localization of SELP protein]; Heparin inhibits the reaction [F2 protein results in increased cleavage of F2R protein]; Heparin inhibits the reaction [F2 protein results in increased expression of EDN1 mRNA]; Heparin inhibits the reaction [F2 protein results in increased secretion of EDN1 protein] Heparin results in increased expression of [F2 protein binds to SERPINC1 protein] Heparin results in decreased expression of F2 protein Heparin deficiency results in increased expression of F2 protein; Heparin results in increased expression of F2 protein |
CTD |
PMID:7509996 PMID:7895349 PMID:8408661 PMID:9740346 PMID:11869846 PMID:16391376 PMID:16961586 PMID:19468011 More...
|
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
multiple interactions |
ISO |
Heparin inhibits the reaction [F2 protein results in increased cleavage of F2R protein] |
CTD |
PMID:19468011 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Heparin results in increased expression of FAS protein |
CTD |
PMID:15205081 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
affects binding |
ISO |
[Heparin binds to PF4 protein] which binds to FCGR2A protein |
CTD |
PMID:8282825 |
|
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Fga |
fibrinogen alpha chain |
increases cleavage |
ISO |
Heparin deficiency results in increased cleavage of FGA protein |
CTD |
PMID:7895349 |
|
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions affects binding |
ISO EXP |
[Heparin analog binds to FGFR2 protein alternative form] which binds to and results in increased activity of FGF1 protein; Heparin analog promotes the reaction [FGF1 protein binds to FGF1 protein] [Heparin binds to FGFR2 protein alternative form] which binds to FGF1 protein Heparin affects the reaction [FGF1 protein binds to FGFR4 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of AKT1 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K1 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K2 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAPK1 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAPK3 protein]; Heparin promotes the reaction [FGF1 protein results in increased expression of FGF1 protein] Heparin promotes the reaction [FGFR1 protein binds to FGF1 protein]; Heparin promotes the reaction [FGFR3 protein binds to FGF1 protein] |
CTD |
PMID:1379594 PMID:8576258 PMID:10336501 PMID:10860838 PMID:14966081 PMID:16219767 More...
|
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
multiple interactions |
ISO |
Heparin promotes the reaction [FGF10 protein binds to FGFR2 protein] |
CTD |
PMID:15632068 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
affects binding multiple interactions |
ISO |
Heparin binds to FGF19 protein Heparin promotes the reaction [FGF19 protein binds to FGFR4 protein] |
CTD |
PMID:10525310 PMID:14730967 |
|
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
affects binding decreases expression multiple interactions affects activity |
ISO EXP |
Heparin binds to FGF2 protein; Heparin binds to FGFR1 protein binds to FGF2 protein Heparin results in decreased expression of FGF2 protein [Heparin binds to FGFR2 protein alternative form] which binds to FGF2 protein Heparin affects the reaction [FGF2 protein binds to FGFR4 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K2 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] Heparin affects the activity of FGF2 protein Heparin promotes the reaction [FGFR1 protein binds to FGF2 protein]; Heparin promotes the reaction [FGFR2 protein binds to FGF2 protein] |
CTD |
PMID:1373495 PMID:1379594 PMID:8441232 PMID:10336501 PMID:10860838 PMID:14966081 PMID:15096041 PMID:15232299 PMID:17524524 More...
|
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
increases activity |
ISO |
Heparin analog results in increased activity of FGF23 protein |
CTD |
PMID:16081635 |
|
NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:159,914,272...159,923,821
|
|
G |
Fgf3 |
fibroblast growth factor 3 |
affects activity |
ISO |
Heparin affects the activity of FGF3 protein |
CTD |
PMID:7592624 |
|
NCBI chr 1:200,001,162...200,005,539
Ensembl chr 1:200,001,261...200,005,187
|
|
G |
Fgf4 |
fibroblast growth factor 4 |
multiple interactions |
ISO |
Heparin binds to and results in increased activity of FGF4 protein |
CTD |
PMID:11486033 |
|
NCBI chr 1:200,023,937...200,027,793
Ensembl chr 1:200,024,056...200,025,466
|
|
G |
Fgf5 |
fibroblast growth factor 5 |
affects activity |
ISO |
Heparin affects the activity of FGF5 protein |
CTD |
PMID:8386828 |
|
NCBI chr14:11,323,827...11,346,164
Ensembl chr14:11,325,334...11,345,997
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
affects binding |
EXP |
[Heparin binds to FGFR2 protein alternative form] which binds to FGF7 protein |
CTD |
PMID:10860838 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
affects binding multiple interactions |
ISO |
Heparin binds to FGFR1 protein binds to FGF2 protein Heparin promotes the reaction [FGFR1 protein binds to FGF1 protein]; Heparin promotes the reaction [FGFR1 protein binds to FGF2 protein] |
CTD |
PMID:1379594 PMID:15096041 |
|
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
multiple interactions affects binding affects activity |
ISO EXP |
[Heparin analog binds to FGFR2 protein alternative form] which binds to and results in increased activity of FGF1 protein; Heparin promotes the reaction [FGF10 protein binds to FGFR2 protein] [Heparin binds to FGFR2 protein alternative form] which binds to FGF1 protein; [Heparin binds to FGFR2 protein alternative form] which binds to FGF2 protein; [Heparin binds to FGFR2 protein alternative form] which binds to FGF7 protein Heparin promotes the reaction [FGFR2 protein binds to FGF2 protein] Heparin affects the activity of FGFR2 protein |
CTD |
PMID:1373495 PMID:10860838 PMID:15632068 PMID:16219767 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
affects activity multiple interactions |
ISO |
Heparin affects the activity of FGFR3 protein Heparin promotes the reaction [FGFR3 protein binds to FGF1 protein] |
CTD |
PMID:1379594 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
affects binding multiple interactions |
ISO EXP |
Heparin analog binds to FGFR4 protein Heparin affects the reaction [FGF1 protein binds to FGFR4 protein]; Heparin affects the reaction [FGF2 protein binds to FGFR4 protein] Heparin promotes the reaction [FGF19 protein binds to FGFR4 protein]; Heparin promotes the reaction [FGFR4 protein binds to FGFR4 protein] |
CTD |
PMID:10336501 PMID:10525310 PMID:10736564 PMID:11278860 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression decreases expression multiple interactions |
ISO EXP |
Heparin results in increased expression of FOS protein Heparin results in decreased expression of FOS mRNA Heparin inhibits the reaction [4-O-methyl-12-O-tetradecanoylphorbol 13-acetate results in increased expression of FOS mRNA] |
CTD |
PMID:2099192 PMID:9083085 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gata4 |
GATA binding protein 4 |
multiple interactions |
EXP |
Heparin inhibits the reaction [Inositol 1,4,5-Trisphosphate results in increased expression of GATA4 protein] |
CTD |
PMID:16259952 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
affects degradation |
ISO |
GNS affects the degradation of Heparin |
CTD |
PMID:3391615 |
|
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
Heparin inhibits the reaction [Diclofenac promotes the reaction [endotoxin, Escherichia coli results in increased activity of GPT protein]] |
CTD |
PMID:31813902 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gzmb |
granzyme B |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of GZMB mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
decreases expression decreases secretion multiple interactions |
ISO |
Heparin results in decreased expression of HAMP mRNA Heparin results in decreased secretion of HAMP protein modified form Heparin inhibits the reaction [BMP6 protein results in increased expression of HAMP mRNA]; Heparin inhibits the reaction [BMP6 protein results in increased secretion of HAMP protein modified form]; Heparin inhibits the reaction [IL6 protein results in increased expression of HAMP mRNA] |
CTD |
PMID:25633564 PMID:25686467 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions affects binding increases expression |
ISO |
Heparin promotes the reaction [HGF protein binds to and results in increased activity of MET protein] HGF protein binds to Heparin Heparin results in increased expression of HGF protein |
CTD |
PMID:9083085 PMID:18243369 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [endotoxin, Escherichia coli results in increased expression of HMOX1 mRNA] |
CTD |
PMID:31813902 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hpse |
heparanase |
multiple interactions |
ISO |
[Heparin results in decreased activity of HPSE protein] which affects the abundance of Heparitin Sulfate |
CTD |
PMID:17121850 |
|
NCBI chr14:8,896,593...8,937,011
Ensembl chr14:8,896,593...8,937,010
|
|
G |
Hrg |
histidine-rich glycoprotein |
multiple interactions |
ISO |
Heparin inhibits the reaction [Zinc results in increased activity of HRG protein] |
CTD |
PMID:8690451 |
|
NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
|
|
G |
Igsf10 |
immunoglobulin superfamily, member 10 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IGSF10 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 2:143,575,710...143,605,044
Ensembl chr 2:143,576,070...143,604,773
|
|
G |
Il6 |
interleukin 6 |
increases expression increases secretion multiple interactions |
ISO EXP |
Heparin results in increased expression of IL6 protein Heparin analog results in increased secretion of IL6 protein Heparin inhibits the reaction [IL6 protein results in increased expression of HAMP mRNA] Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IL6 mRNA] |
CTD |
PMID:16391376 PMID:16401727 PMID:25633564 PMID:26476401 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgam |
integrin subunit alpha M |
decreases expression increases expression |
ISO |
Heparin results in decreased expression of ITGAM protein Heparin results in increased expression of ITGAM protein |
CTD |
PMID:8595612 PMID:8993250 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgax |
integrin subunit alpha X |
decreases expression |
ISO |
Heparin results in decreased expression of ITGAX protein |
CTD |
PMID:8993250 |
|
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Heparin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of JUN protein] |
CTD |
PMID:1730747 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of KLF4 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Krt18 |
keratin 18 |
increases expression |
ISO |
Heparin results in increased expression of KRT18 protein |
CTD |
PMID:15671997 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
|
|
G |
Ldhb |
lactate dehydrogenase B |
decreases expression |
EXP |
Heparin results in decreased expression of LDHB protein |
CTD |
PMID:17488504 |
|
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions |
EXP ISO |
[etofibrate co-treated with Heparin] results in increased secretion of LPL protein Heparin results in increased expression of and results in increased activity of LPL protein |
CTD |
PMID:2313202 PMID:3179329 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K1 protein] |
CTD |
PMID:14966081 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
multiple interactions |
EXP |
Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K2 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K2 protein] |
CTD |
PMID:14966081 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases activity |
ISO EXP |
Heparin analog inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] Heparin inhibits the reaction [sodium chlorate results in decreased phosphorylation of MAPK1 protein] Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAPK1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] Heparin results in increased activity of MAPK1 protein |
CTD |
PMID:14966081 PMID:16556679 PMID:18057711 PMID:19937756 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases activity |
ISO EXP |
Heparin analog inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein] Heparin inhibits the reaction [sodium chlorate results in decreased phosphorylation of MAPK3 protein] Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAPK3 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] Heparin results in increased activity of MAPK3 protein |
CTD |
PMID:14966081 PMID:16556679 PMID:18057711 PMID:19937756 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
Heparin promotes the reaction [MAPT protein binds to MAPT protein]; Mercuric Chloride promotes the reaction [Heparin promotes the reaction [MAPT protein binds to MAPT protein]] |
CTD |
PMID:20665688 PMID:31678113 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mcpt4 |
mast cell protease 4 |
increases activity |
EXP |
Heparin increases activity of Mcpt4 protein |
RGD |
PMID:11896050 |
RGD:633287 |
NCBI chr15:29,501,595...29,504,216
Ensembl chr15:29,501,595...29,504,214
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
multiple interactions |
ISO |
Heparin promotes the reaction [HGF protein binds to and results in increased activity of MET protein] |
CTD |
PMID:9083085 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mif |
macrophage migration inhibitory factor |
affects binding |
ISO |
MIF protein binds to Heparin |
CTD |
PMID:26852939 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
decreases activity |
ISO |
Heparin results in decreased activity of MMP1 protein |
CTD |
PMID:10958381 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
decreases expression |
ISO |
Heparin analog results in decreased expression of MMP14 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases activity |
ISO |
Heparin results in decreased activity of MMP2 protein |
CTD |
PMID:10958381 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases activity increases expression multiple interactions |
ISO |
Heparin results in decreased activity of MMP9 protein Heparin results in increased expression of MMP9 mRNA; Heparin results in increased expression of MMP9 protein Heparin results in increased metabolism of and results in increased activity of MMP9 protein |
CTD |
PMID:10958381 PMID:14630814 PMID:16190367 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
Heparin inhibits the reaction [4-amino-TEMPO inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[1,6-diaminohexane binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[Cadaverine binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[Putrescine binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[Spermine binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[trimethylenediamine binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]] |
CTD |
PMID:34085520 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Msn |
moesin |
increases expression |
EXP |
Heparin results in increased expression of MSN protein |
CTD |
PMID:17488504 |
|
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression decreases expression |
ISO EXP |
Heparin results in increased expression of MYC protein Heparin results in decreased expression of MYC mRNA |
CTD |
PMID:2099192 PMID:11787776 PMID:16475731 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nfatc3 |
nuclear factor of activated T-cells 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [Inositol 1,4,5-Trisphosphate results in increased expression of NFATC3 protein] |
CTD |
PMID:16259952 |
|
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression |
ISO |
Heparin analog results in increased expression of NFE2L2 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Park7 |
Parkinsonism associated deglycase |
increases expression |
EXP |
Heparin results in increased expression of PARK7 protein |
CTD |
PMID:17488504 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
Heparin promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] |
CTD |
PMID:30377735 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
affects expression |
EXP |
Heparin affects the expression of PDGFB protein |
CTD |
PMID:8441232 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
decreases expression |
ISO |
Heparin results in decreased expression of PDGFRA mRNA |
CTD |
PMID:16945567 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
decreases expression |
EXP |
Heparin results in decreased expression of PDHB protein |
CTD |
PMID:17488504 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pf4 |
platelet factor 4 |
affects binding increases secretion |
ISO |
[Heparin binds to PF4 protein] which binds to FCGR2A protein; Heparin binds to PF4 protein Heparin results in increased secretion of PF4 protein |
CTD |
PMID:2437338 PMID:2709525 PMID:8282825 PMID:20162249 |
|
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
|
|
G |
Pitpna |
phosphatidylinositol transfer protein, alpha |
increases expression |
EXP |
Heparin results in increased expression of PITPNA protein |
CTD |
PMID:17488504 |
|
NCBI chr10:60,430,712...60,473,564
Ensembl chr10:60,430,748...60,471,342
|
|
G |
Plat |
plasminogen activator, tissue type |
increases expression |
ISO |
Heparin results in increased expression of PLAT mRNA; Heparin results in increased expression of PLAT protein |
CTD |
PMID:14630814 PMID:16190367 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plau |
plasminogen activator, urokinase |
decreases expression |
ISO |
Heparin analog results in decreased expression of PLAU mRNA |
CTD |
PMID:26476401 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plg |
plasminogen |
multiple interactions |
ISO |
Heparin inhibits the reaction [PLG protein affects the degradation of CCL11 protein] |
CTD |
PMID:17384413 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Ppbp |
pro-platelet basic protein |
increases secretion |
ISO |
Heparin results in increased secretion of PPBP protein |
CTD |
PMID:2437338 |
|
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
increases activity |
ISO |
Heparin deficiency results in increased activity of PROC protein |
CTD |
PMID:7895349 |
|
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Psmb5 |
proteasome 20S subunit beta 5 |
decreases activity decreases expression |
ISO |
Heparin analog results in decreased activity of PSMB5 protein Heparin analog results in decreased expression of PSMB5 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
|
|
G |
Psmb6 |
proteasome 20S subunit beta 6 |
decreases expression |
ISO |
Heparin analog results in decreased expression of PSMB6 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr10:55,239,256...55,241,586
Ensembl chr10:55,239,241...55,241,586
|
|
G |
Psmb7 |
proteasome 20S subunit beta 7 |
decreases expression |
ISO |
Heparin analog results in decreased expression of PSMB7 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 3:22,357,777...22,417,748
Ensembl chr 3:22,354,698...22,417,937
|
|
G |
Psme1 |
proteasome activator subunit 1 |
increases expression |
EXP |
Heparin results in increased expression of PSME1 protein |
CTD |
PMID:17488504 |
|
NCBI chr15:29,069,012...29,071,888
Ensembl chr15:29,068,729...29,071,890
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of PTGS2 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases phosphorylation |
ISO |
Heparin results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:18674534 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Pxn |
paxillin |
decreases phosphorylation |
ISO |
Heparin results in decreased phosphorylation of PXN protein |
CTD |
PMID:18674534 |
|
NCBI chr12:41,060,791...41,107,952
Ensembl chr12:41,060,791...41,107,931
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of RAC1 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
Heparin analog results in decreased expression of and results in decreased phosphorylation of RB1 protein |
CTD |
PMID:20201787 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Heparin inhibits the reaction [arsenite affects the localization of RELA protein]; Heparin inhibits the reaction [TNF protein affects the localization of RELA protein] |
CTD |
PMID:10843908 PMID:26677073 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
S100a1 |
S100 calcium binding protein A1 |
affects expression |
EXP |
Heparin affects the expression of S100A1 protein |
CTD |
PMID:12186470 |
|
NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544
|
|
G |
S100a6 |
S100 calcium binding protein A6 |
affects expression increases expression |
EXP |
Heparin affects the expression of S100A6 protein Heparin results in increased expression of S100A6 protein |
CTD |
PMID:12186470 PMID:17488504 |
|
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
|
|
G |
S100b |
S100 calcium binding protein B |
affects expression |
EXP |
Heparin affects the expression of S100B protein |
CTD |
PMID:12186470 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sdc1 |
syndecan 1 |
decreases expression |
ISO |
Heparin analog results in decreased expression of SDC1 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
|
|
G |
Sdc2 |
syndecan 2 |
decreases expression |
ISO |
Heparin analog results in decreased expression of SDC2 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
|
|
G |
Sdc4 |
syndecan 4 |
increases expression |
ISO |
Heparin analog results in increased expression of SDC4 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
|
|
G |
Sell |
selectin L |
decreases expression increases expression |
ISO |
Heparin results in decreased expression of SELL protein Heparin results in increased expression of SELL protein |
CTD |
PMID:8595612 PMID:8993250 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Selp |
selectin P |
multiple interactions increases expression |
ISO |
Heparin inhibits the reaction [F2 protein affects the localization of SELP protein]; Heparin promotes the reaction [Adenosine Diphosphate affects the localization of SELP protein] Heparin results in increased expression of SELP protein |
CTD |
PMID:9740346 PMID:10544909 |
|
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
|
|
G |
Septin2 |
septin 2 |
increases expression |
EXP |
Heparin results in increased expression of SEPTIN2 protein |
CTD |
PMID:17488504 |
|
NCBI chr 9:94,018,141...94,051,386
Ensembl chr 9:94,018,208...94,051,386
|
|
G |
Serpinc1 |
serpin family C member 1 |
decreases expression multiple interactions |
ISO |
Heparin deficiency results in decreased expression of SERPINC1 protein; Heparin results in decreased expression of SERPINC1 protein Heparin results in increased expression of [F2 protein binds to SERPINC1 protein] Heparin deficiency results in increased expression of [SERPINC1 protein binds to F2 protein] |
CTD |
PMID:73932 PMID:7895349 PMID:8122184 PMID:11869846 PMID:16961586 |
|
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SERPINE1 protein]]; Heparin promotes the reaction [[Famotidine co-treated with Lipopolysaccharides] results in increased expression of SERPINE1 protein] |
CTD |
PMID:16401727 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sfrp1 |
secreted frizzled-related protein 1 |
multiple interactions |
EXP |
Heparin promotes the reaction [Doxorubicin results in increased secretion of SFRP1 protein] |
CTD |
PMID:30377735 |
|
NCBI chr16:68,575,763...68,614,180
Ensembl chr16:68,575,763...68,614,286
|
|
G |
Slc5a3 |
solute carrier family 5 member 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of SLC5A3 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883
|
|
G |
Slk |
STE20-like kinase |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of SLK mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 1:246,473,712...246,529,643
Ensembl chr 1:246,473,712...246,526,530
|
|
G |
Stip1 |
stress-induced phosphoprotein 1 |
increases expression |
EXP |
Heparin results in increased expression of STIP1 protein |
CTD |
PMID:17488504 |
|
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
|
|
G |
Tagln2 |
transgelin 2 |
decreases expression |
EXP |
Heparin results in decreased expression of TAGLN2 protein |
CTD |
PMID:17488504 |
|
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions decreases expression |
EXP ISO |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of TFRC mRNA] Heparin results in decreased expression of TFRC protein |
CTD |
PMID:16401727 PMID:25633564 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
EXP |
Heparin results in decreased expression of TGFB1 mRNA |
CTD |
PMID:15149336 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
Heparin inhibits the reaction [TNF protein affects the localization of RELA protein] Heparin results in increased expression of TNF protein |
CTD |
PMID:10843908 PMID:17162433 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression |
ISO |
Heparin analog results in decreased expression of TP53 protein |
CTD |
PMID:20201787 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vegfa |
vascular endothelial growth factor A |
affects binding |
ISO |
Heparin binds to VEGFA protein alternative form |
CTD |
PMID:20376344 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
increases chemical synthesis |
ISO |
B3GNT2 protein results in increased chemical synthesis of Keratan Sulfate |
CTD |
PMID:12218059 |
|
NCBI chr14:96,808,473...96,833,674
Ensembl chr14:96,806,664...96,835,273
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
increases chemical synthesis |
ISO |
B4GALT1 protein results in increased chemical synthesis of Keratan Sulfate |
CTD |
PMID:12218059 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
Chst5 |
carbohydrate sulfotransferase 5 |
multiple interactions |
ISO |
CHST6 protein results in increased sulfation of and results in increased chemical synthesis of Keratan Sulfate |
CTD |
PMID:12218059 |
|
NCBI chr19:39,860,729...39,881,019
Ensembl chr19:39,860,501...39,881,064
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
affects degradation |
ISO |
GNS affects the degradation of Keratan Sulfate |
CTD |
PMID:3391615 |
|
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
|
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
laurolactam binds to and results in decreased activity of AR protein |
CTD |
PMID:27633901 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
laurolactam binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:27633901 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
laurolactam binds to and results in decreased activity of NR3C1 protein |
CTD |
PMID:27633901 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
laurolactam binds to and results in decreased activity of PGR protein |
CTD |
PMID:27633901 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
mycotrienin I inhibits the reaction [TNF protein results in increased expression of and affects the localization of ICAM1 protein] |
CTD |
PMID:21448188 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
mycotrienin I inhibits the reaction [TNF protein results in increased expression of and affects the localization of ICAM1 protein] |
CTD |
PMID:21448188 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|